Innate Pharma (IPHA) Interest Coverage Ratio (2019 - 2025)
Innate Pharma (IPHA) reported Interest Coverage Ratio of 16.76 for Q4 2025, up 24.66% on a YoY basis from 13.45 in Q4 2024, and up 84.78% quarter-over-quarter from 9.07 in Q2 2025.
Innate Pharma (IPHA) Interest Coverage Ratio (2019 - 2025) Analysis & Trends
Innate Pharma has reported Interest Coverage Ratio for 7 years, with the latest figure at 16.76 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio rose 24.66% year-over-year to 16.76; the trailing twelve-month figure through Dec 2025 stood at 13.19 (up 30.48% YoY), and the FY2025 full-year result was 17.31, down 33.41% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 16.76, up from 9.07 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 16.76 in Q4 2025, with the low at 0.41 in Q2 2023.
- Historically, Interest Coverage Ratio has averaged 10.18 across 5 years, with a median of 11.93 in 2021.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 56.91% — and 2024, when it jumped 2994.25%.
- Innate Pharma's Interest Coverage Ratio stood at 11.97 in 2021, then dropped by 0.59% to 11.89 in 2022, then slumped by 56.91% to 5.13 in 2023, then surged by 162.33% to 13.45 in 2024, then grew by 24.66% to 16.76 in 2025.
- The last three Interest Coverage Ratio figures came in at 16.76 (Q4 2025), 9.07 (Q2 2025), and 13.45 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | Innate Pharma | 194.19 Mn | 194.19 Mn | - | 16.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.76 |
| Jun 30, 2025 | 9.07 |
| Dec 31, 2024 | 13.45 |
| Jun 30, 2024 | 12.75 |
| Dec 31, 2023 | 5.13 |
| Jun 30, 2023 | 0.41 |
| Dec 31, 2022 | 11.89 |
| Dec 31, 2021 | 11.97 |
| Dec 31, 2020 | 1.12 |
| Jun 30, 2020 | 1.88 |
| Dec 31, 2019 | 5.17 |